Agteria Biotech is a Swedish startup founded in 2023 developing a patent-pending molecule that significantly reduces methane emissions from cattle. The company positions its solution as scalable, low-cost, and offering the highest methane reduction per euro. Agteria has demonstrated high efficacy in several in-vivo trials and has attracted interest from beef and dairy companies as well as animal feed companies. The team’s stated goal is to contribute to a 1 percent reduction in global greenhouse gas emissions by targeting enteric methane. The new €6 million seed financing will support advancement toward regulatory approval and essential safety studies for animals, consumers, and the environment. Leadership emphasizes safety, scalability, and affordability as core priorities. Agteria Biotech is developing a patent-pending enzyme-blocking feed additive aimed at reducing methane emissions from cattle. The product is based on research from the Royal Institute of Technology (KTH) and the company says it is nearly 100 times more affordable than red seaweed. Agteria is collaborating with world-class universities and regulatory authorities to validate efficacy and safety, and has secured letters of intent with several large European players. The startup is conducting in-vivo studies and working on production scaling with a target of commercial sales by 2026. Financially, Agteria recently closed a €1.4M pre-seed round led by Norrsken Launcher to advance development and commercialization efforts.

Total raised

$9M

Funding rounds

2

Latest round

Seed

Latest activity

Feb 2025